Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$207.02 - $241.31 $7.43 Million - $8.66 Million
-35,872 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$207.01 - $276.09 $147,184 - $196,299
-711 Reduced 1.94%
35,872 $8.48 Million
Q3 2020

Nov 13, 2020

SELL
$255.65 - $303.1 $110,440 - $130,939
-432 Reduced 1.17%
36,583 $9.96 Million
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $73,506 - $96,430
326 Added 0.89%
37,015 $10.7 Million
Q4 2019

Feb 19, 2020

BUY
$166.71 - $223.91 $11,669 - $15,673
70 Added 0.19%
36,689 $8.03 Million
Q3 2019

Nov 05, 2019

BUY
$166.23 - $187.09 $15,293 - $17,212
92 Added 0.25%
36,619 $6.2 Million
Q2 2019

Aug 12, 2019

BUY
$164.61 - $190.37 $8,888 - $10,279
54 Added 0.15%
36,527 $6.7 Million
Q1 2019

May 07, 2019

BUY
$163.73 - $194.7 $72,532 - $86,252
443 Added 1.23%
36,473 $6.71 Million
Q4 2018

Feb 13, 2019

BUY
$151.91 - $192.21 $15,798 - $19,989
104 Added 0.29%
36,030 $5.97 Million
Q3 2018

Nov 13, 2018

BUY
$167.73 - $192.74 $29,017 - $33,344
173 Added 0.48%
35,926 $6.92 Million
Q2 2018

Aug 14, 2018

BUY
$145.72 - $169.96 $56,247 - $65,604
386 Added 1.09%
35,753 $6.08 Million
Q1 2018

May 14, 2018

BUY
$151.6 - $177.13 $21,224 - $24,798
140 Added 0.4%
35,367 $5.76 Million
Q4 2017

Feb 14, 2018

BUY
$137.28 - $155.55 $31,299 - $35,465
228 Added 0.65%
35,227 $5.28 Million
Q3 2017

Nov 13, 2017

BUY
$148.13 - $162.24 $5.18 Million - $5.68 Million
34,999
34,999 $5.32 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Mason Street Advisors, LLC Portfolio

Follow Mason Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mason Street Advisors, LLC with notifications on news.